Predicting and treating seizures after brain bleeding
Precise Prediction and Treatment of Seizures After Intracranial Hemorrhage
This study is looking to help people who have had bleeding in the brain by finding better ways to predict and prevent seizures, so they can get the right treatment and improve their recovery and quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10811744 on NIH RePORTER |
What this research studies
This research focuses on improving the prediction and treatment of seizures that can occur after intracranial hemorrhage, a type of brain injury caused by bleeding. The study aims to develop better methods to identify patients at risk for seizures and to determine who would benefit from preventive medications. By analyzing clinical data and using algorithms, the researchers hope to enhance the accuracy of seizure predictions and optimize the use of antiseizure medications, which can sometimes lead to complications. This approach seeks to improve patient outcomes and quality of life following brain hemorrhage.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who have suffered an intracranial hemorrhage and are at risk for developing seizures.
Not a fit: Patients who have not experienced an intracranial hemorrhage or those with pre-existing seizure disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention of seizures and better overall recovery for patients who experience intracranial hemorrhage.
How similar studies have performed: Previous research has shown that improving seizure prediction and treatment can lead to better patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Naidech, Andrew M — Northwestern University at Chicago
- Study coordinator: Naidech, Andrew M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.